Ronald A. Evans
Edgewood Chemical Biological Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Ronald A. Evans.
Analytical Chemistry | 2010
Jennifer L. S. Sporty; Sharon W. Lemire; Edward M. Jakubowski; Julie A. Renner; Ronald A. Evans; Robert F. Williams; Jurgen G. Schmidt; Marcel J. van der Schans; Daan Noort; Rudolph C. Johnson
A novel method for extracting butyrylcholinesterase (BuChE) from serum as a means of identifying and measuring nerve agent adducts to human BuChE is presented here. Antibutyrylcholinesterase monoclonal antibodies were conjugated to protein-G ferromagnetic particles and mixed with 500 microL serum samples. The particle-antibody-BuChE product was rinsed and directly digested with pepsin. Native and isotopically enriched nonapeptides corresponding to the pepsin digest products for uninhibited BuChE, and sarin, cyclohexylsarin, VX, and Russian VX nerve agent-inhibited BuChE were synthesized for use as calibrators and internal standards, respectively. Internal standards were added to the filtered digest sample, and the samples were quantified via high performance liquid chromatography-isotope dilution-tandem mass spectrometry. The ratio of adducted to total BuChE nonapeptides was calculated for each nerve agent-exposed serum sample using data collected in a single chromatogram. Nerve agent-inhibited quality control serum pools were characterized as part of method validation; the method was observed to have extremely low background noise. The measurement of both uninhibited and inhibited BuChE peptides compensated for any variations in the pepsin digestion before the internal standard peptide was added to the sample and may prove useful in individualizing patient results following a nerve agent exposure.
Analytical Chemistry | 2014
Brian S. Crow; Brooke G. Pantazides; Jennifer Quiñones-González; Joshua W. Garton; Melissa D. Carter; Jonas W. Perez; Caroline Watson; Dennis J. Tomcik; Michael D. Crenshaw; Bobby N. Brewer; James R. Riches; Sarah J. Stubbs; Robert W. Read; Ronald A. Evans; Jerry D. Thomas; Thomas A. Blake; Rudolph C. Johnson
This work describes a new specific, sensitive, and rapid stable isotope dilution method for the simultaneous detection of the organophosphorus nerve agents (OPNAs) tabun (GA), sarin (GB), soman (GD), cyclosarin (GF), VR, VX, and VM adducts to tyrosine (Tyr). Serum, plasma, and lysed whole blood samples (50 μL) were prepared by protein precipitation followed by digestion with Pronase. Specific Tyr adducts were isolated from the digest by a single solid phase extraction (SPE) step, and the analytes were separated by reversed-phase ultra high performance liquid chromatography (UHPLC) gradient elution in less than 2 min. Detection was performed on a triple quadrupole tandem mass spectrometer using time-triggered selected reaction monitoring (SRM) in positive electrospray ionization (ESI) mode. The calibration range was characterized from 0.100-50.0 ng/mL for GB- and VR-Tyr and 0.250-50.0 ng/mL for GA-, GD-, GF-, and VX/VM-Tyr (R(2) ≥ 0.995). Inter- and intra-assay precision had coefficients of variation of ≤17 and ≤10%, respectively, and the measured concentration accuracies of spiked samples were within 15% of the targeted value for multiple spiking levels. The limit of detection was calculated to be 0.097, 0.027, 0.018, 0.074, 0.023, and 0.083 ng/mL for GA-, GB-, GD-, GF-, VR-, and VX/VM-Tyr, respectively. A convenience set of 96 serum samples with no known nerve agent exposure was screened and revealed no baseline values or potential interferences. This method provides a simple and highly specific diagnostic tool that may extend the time postevent that a confirmation of nerve agent exposure can be made with confidence.
Analytical Chemistry | 2012
Jennifer S. Knaack; Yingtao Zhou; Carter W. Abney; Samantha M. Prezioso; Matthew L. Magnuson; Ronald A. Evans; Edward M. Jakubowski; Katelyn Hardy; Rudolph C. Johnson
We have developed a novel immunomagnetic scavenging technique for extracting cholinesterase inhibitors from aqueous matrixes using biological targeting and antibody-based extraction. The technique was characterized using the organophosphorus nerve agent VX. The limit of detection for VX in high-performance liquid chromatography (HPLC)-grade water, defined as the lowest calibrator concentration, was 25 pg/mL in a small, 500 μL sample. The method was characterized over the course of 22 sample sets containing calibrators, blanks, and quality control samples. Method precision, expressed as the mean relative standard deviation, was less than 9.2% for all calibrators. Quality control sample accuracy was 102% and 100% of the mean for VX spiked into HPLC-grade water at concentrations of 2.0 and 0.25 ng/mL, respectively. This method successfully was applied to aqueous extracts from soil, hamburger, and finished tap water spiked with VX. Recovery was 65%, 81%, and 100% from these matrixes, respectively. Biologically based extractions of organophosphorus compounds represent a new technique for sample extraction that provides an increase in extraction specificity and sensitivity.
Analytical Chemistry | 2011
Ronald A. Evans; Wendy L. Smith; Nam-Phuong Nguyen; Kathy L. Crouse; Charles L. Crouse; Steven D. Norman; E. Michael Jakubowski
An analysis method has been developed for determining low parts-per-quadrillion by volume (ppqv) concentrations of nerve agent VX vapor actively sampled from ambient air. The method utilizes glass bead filled depot area air monitoring system (DAAMS) sampling tubes with isopropyl alcohol extraction and isotope dilution using liquid chromatography coupled with a triple-quadrupole mass spectrometer (LC/MS/MS) with positive ion electrospray ionization for quantitation. The dynamic range was from one-tenth of the worker population limit (WPL) to the short-term exposure limit (STEL) for a 24 L air sample taken over a 1 h period. The precision and accuracy of the method were evaluated using liquid-spiked tubes, and the collection characteristics of the DAAMS tubes were assessed by collecting trace level vapor generated in a 1000 L continuous flow chamber. The method described here has significant improvements over currently employed thermal desorption techniques that utilize a silver fluoride pad during sampling to convert VX to a higher volatility G-analogue for gas chromatographic analysis. The benefits of this method are the ability to directly analyze VX with improved selectivity and sensitivity, the injection of a fraction of the extract, quantitation using an isotopically labeled internal standard, and a short instrument cycle time.
Journal of Analytical Toxicology | 2004
Edward M. Jakubowski; Jeffrey M. McGuire; Ronald A. Evans; J.L. Edwards; Stanley W. Hulet; B.J. Benton; J.S. Forster; D.C. Burnett; William T. Muse; Kathy L. Matson; C.L. Crouse; Robert J. Mioduszewski; Sandra A. Thomson
Journal of Analytical Toxicology | 2008
Ronald A. Evans; Edward M. Jakubowski; William T. Muse; Kathy L. Matson; Stanley W. Hulet; Robert J. Mioduszewski; Sandra A. Thomson; A.L. Totura; Julie A. Renner; C.L. Crouse
Journal of Analytical Toxicology | 2008
Julie A. Renner; Paul A. Dabisch; Ronald A. Evans; Jeffrey M. McGuire; Allison L. Totura; Edward M. Jakubowski; Sandra A. Thomson
Archive | 2005
Kathy L. Matson; Charles L. Crouse; Dennis B. Miller; Ronald A. Evans; Jeffrey M. McGuire; Jill R. Jarvis; Bernard J. Benton; Douglas R. Sommerville; Jacqueline A. Scotto; David C. Burnett
Archive | 2017
Ronald T. Checkai; Mark V. Haley; Michael Simini; Richard J Lawrence; Roman G. Kuperman; William T. Muse; Ronald A. Evans; Michael W Busch
Archive | 2010
Sharon Reutter-Christry; Douglas R. Sommerville; Edward M. Jakubowski; Christopher E. Whalley; Bernard J. Benton; Stanley W. Hulet; Paul A. Dabisch; Ronald A. Evans; Jeffrey M. McGuire; Christopher E. Byers; James H. Manthei; Ruth W Moretz; Jeffry S. Forster; Bernadita I. Gaviola; David C. Burnett; William T. Muse; Kathy L. Matson; Charles L. Crouse; Robert J. Mioduszewski; Sandra A. Thomson